CA - Theratechnologies Inc. (THTX) Q4 2023 Earnings Call Transcript
2024-02-21 12:41:02 ET
Theratechnologies Inc. (THTX)
Q4 2023 Earnings Conference Call
February 21, 2024, 8:30 AM ET
Company Participants
Julie Schneiderman - Senior Director, Communications and Corporate Affairs
Paul Levesque - President and Chief Executive Officer
Philippe Dubuc - Senior Vice President and Chief Financial Officer
John Leasure - Global Commercial Officer
Christian Marsolais - Senior Vice President and Chief Medical Officer
Conference Call Participants
Carvey Leung - Cantor Fitzgerald
Andre Uddin - Research Capital
Justin Walsh - JonesTrading
William Maughan - Canaccord Genuity
Presentation
Operator
Good morning, ladies and gentlemen, and thank you for standing by. Welcome to Theratechnologies Fourth Quarter and Full Year Fiscal 2023 Earnings Call. We would like to remind everyone that all figures on this call are quoted in US dollars. At this time, all participants are in a listen-only mode. Following the presentation, we will conduct a question-and-answer session with analysts. Instructions will be provided at that time for you to queue up for questions. Following the analyst Q&A session, investors wishing to submit a question may do so by clicking the Ask a Question link on the webcast platform. [Operator Instructions] I would like to remind everyone that this conference call is being recorded today, Wednesday, February 21st, 2024, at 8:30 A.M. Eastern Time.
I will now turn the call over to Julie Schneiderman, Senior Director, Communications and Corporate Affairs at Theratechnologies. Julie, please go ahead.
Julie Schneiderman
Thank you, operator, and good morning, everyone. On the call today will be Theratechnologies' President and Chief Executive Officer, Mr. Paul Levesque; and Senior Vice President and Chief Financial Officer, Mr. Philippe Dubuc. During the Q&A session, we will be joined by Dr. Christian Marsolais, Senior Vice President and Chief Medical Officer; and Mr. John Leasure, the company's Global Commercial Officer.
Before we begin, I'd like to remind everyone that remarks today contain forward-looking statements regarding the company's current and future plans, expectations and intentions with respect to future events. Forward-looking statements are based on assumptions, and there are risks that results obtained by Theratechnologies may differ materially from those statements. As such, the company cannot guarantee that any forward-looking statements will materialize, and you are cautioned not to place undue reliance on them.
The company refers current and potential investors to the forward-looking information section of Theratechnologies' Management Discussion and Analysis issued this morning and available on SEDAR+ at sedarplus.ca and on EDGAR at sec.gov. Forward-looking statements represent Theratechnologies' expectations as of this morning, February 21st, 2024....
Theratechnologies Inc. (THTX) Q4 2023 Earnings Call Transcript